Folate-Targeted PEGylated Magnetoliposomes for Hyperthermia-Mediated Controlled Release of Doxorubicin
Doxorubicin (DOX) is a chemotherapeutic agent commonly used for the treatment of solid tumors. However, the cardiotoxicity associated with its prolonged use prevents further adherence and therapeutic efficacy. By encapsulating DOX within a PEGylated liposome, Doxil® considerably decreased DOX cardio...
Main Authors: | Emílio R. Cintra, Tacio G. Hayasaki, Ailton A. Sousa-Junior, Artur C. G. Silva, Marize C. Valadares, Andris F. Bakuzis, Sebastião A. Mendanha, Eliana M. Lima |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.854430/full |
Similar Items
-
The Therapeutic Potential of Chemo/Thermotherapy with Magnetoliposomes for Cancer Treatment
by: Alfonso Toro-Córdova, et al.
Published: (2022-11-01) -
Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions
by: Farcas CG, et al.
Published: (2020-10-01) -
Bovine Lactoferrin-Loaded Plasmonic Magnetoliposomes for Antifungal Therapeutic Applications
by: Mélanie Pereira, et al.
Published: (2023-08-01) -
Photothermal Properties of IR-780-Based Nanoparticles Depend on Nanocarrier Design: A Comparative Study on Synthetic Liposomes and Cell Membrane and Hybrid Biomimetic Vesicles
by: Júlia Muniz Barcelos, et al.
Published: (2023-01-01) -
Magnetoliposomes Based on Shape Anisotropic Calcium/Magnesium Ferrite Nanoparticles as Nanocarriers for Doxorubicin
by: Beatriz D. Cardoso, et al.
Published: (2021-08-01)